Anti-epileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795)
Rx. Moldrich et al., Anti-epileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795), NEUROPHARM, 41(1), 2001, pp. 8-18
The selective group II metabotropic glutamate receptor (mGlu(2/3)) agonists
(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)
-2-thia-4-aminobicyclo[3.1.0]hexane-4 (LY389795) have been evaluated as ant
i-epileptic drugs in dilute brown agouti (DBA/2) mice, lethargic (lh/lh) mi
ce, genetically epilepsy-prone-9 (GEP) rats and amygdala-kindled rats. Soun
d-induced clonic seizures in DBA/2 mice were transiently inhibited by both
agonists intracerebroventricularly (i.c.v.), LY379268 ED50=0.08 [0.02-0.33]
nmol and LY389795 ED50=0.82 [0.27-3.24] nmol or intraperitoneally (i.p.),
LY379268 ED50=2.9 [0.9-9.6] mg/kg and LY389795 ED50=3.4 [1.0-11.7] mg/kg. B
oth mGlu(2/3) agonists inhibited seizures induced by the group I mGlu recep
tor agonist (R,S)-3,5-dihydroxyphenylglycine (DHPG), where LY379268, i.c.v.
ED50=0.3 [0.02-5.0] pmol and LY389795, i.c.v. ED50=0.03 [0.05-0.19] nmol.
The spike and wave discharge (SWD) duration of absence seizures in lh/lh mi
ce was significantly reduced by both agonists at 1 and 10 nmol (i.c.v.) up
to 90 min following infusion. The electrically induced seizure score and af
terdischarge duration of amygdala-kindled rats was partially inhibited by t
he agonists 30 min after i.p. injection of 10 mg/kg. The agonists did not i
nhibit sound-induced seizures in GEP rats (0.1-1 mg/kg, 30 min 1 h, i.p.),
but were proconvulsant following sound stimulus (greater than or equal to0.
1 mg/kg). These findings identify a potential role for mGlu(2/3) agonists i
n the amelioration of generalised and partial epileptic seizures. (C) 2001
Elsevier Science Ltd. All rights reserved.